Medicine and Dentistry
Patient
100%
Assessment
95%
Glioblastoma
95%
Epileptic Seizure
54%
Brain Tumor
54%
Physical Disease by Body Function
47%
Levetiracetam
47%
Therapeutic Procedure
47%
Prophylaxis
47%
Disease Activity
47%
Experience
47%
Inpatient
20%
Drug Therapy
18%
Surgery
15%
Neuro-Oncology
15%
Follow up
15%
Headache
13%
Life
13%
End of Life Care
13%
Death
13%
Consciousness
13%
Anticonvulsant
12%
Quality of Life
12%
Chemotherapeutic Agent
10%
Drug
10%
Side Effect
10%
Neoplasm
9%
Steroid
6%
Nonsteroid Antiinflammatory Agent
6%
Dying
6%
Cognitive Defect
6%
Plummer-Vinson Syndrome
6%
Ganglioglioma
6%
Opiate
6%
Survival
6%
Fever
6%
Diagnosis
6%
Base
6%
Hospital
6%
Clinical Study
6%
Prospective Study
5%
Somnolence
5%
Debulking
5%
Perioperative Period
5%
Carbohydrate Mixture Plus Electrolytes
5%
Blood Toxicity
5%
Cognition
5%
Health
5%
Plasma
5%
Nursing and Health Professions
Physical Disease by Body Function
47%
Pilot Study
47%
Clinical Outcome
47%
Brain Ischemia
47%
Glioblastoma
47%
Time
47%
Monitoring
47%
Patient
31%
A Wave
31%
Inpatient
15%
Analyzer
15%
Kruskal Wallis Test
15%
Individualization
15%
Area under the Curve
15%
National Institutes of Health Stroke Scale
15%
Cerebrovascular Accident
15%
Parameters
15%
Symptom
15%
Sample
15%
Terminal Care
13%
Combination Therapy
13%
Headache
13%
Death
13%
Drug Therapy
13%
Dying
6%
Steroid
6%
Nonsteroid Antiinflammatory Agent
6%
Seizure
6%
Anticonvulsive Agent
6%
Hospital Setting
6%
Dysphagia
6%
Survival
6%
Glioma
6%
Fever
6%
Quality of Life
6%
Cognitive Defect
6%
Brain Tumor
6%
Practice Guideline
6%
Opiate
6%
Diagnosis
6%
Base
6%
Pharmacology, Toxicology and Pharmaceutical Science
Physical Disease by Body Function
47%
Glioblastoma
47%
Headache
13%
Death
13%
Survival
6%
Fever
6%
Seizure
6%
Anticonvulsive Agent
6%
Brain Tumor
6%
Base
6%
Cognitive Defect
6%
Opiate
6%
Steroids
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Dying
6%
Glioma
6%
Dysphagia
6%
Pharmaceutical Therapy
6%
